195
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Efficacy of transarterial chemoembolization compared with radiofrequency ablation for the treatment of recurrent hepatocellular carcinoma after radiofrequency ablation

, &
Pages 344-352 | Received 27 Aug 2018, Accepted 24 Jun 2019, Published online: 02 Aug 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Dimitrios Papaconstantinou, Diamantis I Tsilimigras & Timothy M Pawlik. (2022) Recurrent Hepatocellular Carcinoma: Patterns, Detection, Staging and Treatment. Journal of Hepatocellular Carcinoma 9, pages 947-957.
Read now

Articles from other publishers (4)

Wenwu Wan, Hao Zhang, Tao Ji, Li Zhang, KaiGuo Luo & Ding Xiong. (2023) Optimal treatment strategy for recurrent hepatocellular carcinoma based on recurrence time and tumor size: A propensity score matching study. Clinics and Research in Hepatology and Gastroenterology 47:7, pages 102157.
Crossref
Cailing Xiang, Yating Xiao, Zhongzhi Ma, Yuchong Peng, Xun Li, Xianhai Mao & Lequn Li. (2022) Liver resection for large and huge hepatocellular carcinoma: Predictors of failure, recurrence patterns, and prognoses. Asia-Pacific Journal of Clinical Oncology 19:2.
Crossref
Christiaan M. C. Serbanescu-Kele Apor de Zalán, Simeon J. S. Ruiter, Aad P. van den Berg, Jan Pieter Pennings & Koert P. de Jong. (2022) Outcomes after primary and repeat thermal ablation of hepatocellular carcinoma with or without liver transplantation. European Radiology 32:6, pages 4168-4176.
Crossref
Haoxian Gou, Shenglu Liu, Gang Zhu, Yisheng Peng, Xinkai Li, Xiaoli Yang & Kai He. (2022) Effectiveness of radiofrequency ablation versus transarterial chemoembolization for recurrent hepatocellular carcinoma: A meta-analysis. Acta Radiologica Open 11:3, pages 205846012210855.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.